Product
FLOT-CROSS
1 clinical trial
2 indications
Indication
Esophageal cancerIndication
Esophageal AdenocarcinomaClinical trial
Total Neoadjuvant Therapy for Adenocarcinoma of the OESophagus and Oesophagogastric Junction: TNT-OES-2 TrialStatus: Not yet recruiting, Estimated PCD: 2029-09-01